Abstract
Because of encouraging results when human leukocyte interferon was given for 5 to 7 days to treat early localized herpes zoster in patients with cancer, a small placebo-controlled, randomized, double-blind trial was set up involving only 48 h of therapy. In this trial, there was no effect on acute pain or disease progression in the primary dermatome. However, a modest but significant effect was noted in that distal cutaneous spread was diminished in the treated patients compared with the controls and the treated patients had diminished severity and duration of postherpetic neuralgia. No evidence of impairment in varicella-zoster-specific lymphocyte transformation was observed in interferon-treated patients.
References
Jun 16, 1977·The New England Journal of Medicine·K H RandT C Merigan
Oct 1, 1977·The Journal of Pediatrics·S FeldmanE Epp
May 4, 1978·The New England Journal of Medicine·T C MeriganR P Fried
Dec 1, 1979·Annals of Internal Medicine·J G Gallagher, T C Merigan
Apr 1, 1980·The Journal of Clinical Investigation·A M ArvinT C Merigan
Citations
Jan 1, 1994·Biotherapy·N B Finter
Aug 1, 1984·European Journal of Clinical Microbiology·P G Higgins
Mar 1, 1984·The American Journal of Medicine·K K Wong, M S Hirsch
Apr 1, 1984·European Journal of Cancer & Clinical Oncology·J Wildiers, E De Clercq
Aug 1, 1990·Australian Dental Journal·A P Barrett
Jan 1, 1985·Antiviral Research·P S Lietman, R Saral
Jun 1, 1991·Journal of the American Academy of Dermatology·T A Luger, T Schwarz
Dec 28, 2006·Journal of the American Academy of Dermatology·David I SmithMichael P Heffernan
Sep 1, 1996·Infectious Disease Clinics of North America·A M Arvin
Jan 15, 1999·International Journal of Dermatology·D S Hurd, E T Conte
Jun 1, 1986·International Journal of Dermatology·Q S Ringenberg, P C Anderson
Sep 24, 1982·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·G M Scott
Sep 24, 1982·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·T C Merigan
Apr 3, 2002·Current Infectious Disease Reports·Mark Dybul
Nov 1, 1983·The British Journal of Ophthalmology·J McGill, C Chapman
Apr 1, 1988·International Journal of Dermatology·P DuschetF Gschnait
Jan 1, 1988·Pharmacotherapy·G L StrommenC L Beck
Jan 1, 1982·Acta Medica Scandinavica. Supplementum·M L KoskiniemiK Cantell